BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Common Stock, $0.00005 par value
Symbol
BCLI on OTC
Shares outstanding
6,002,966
Price per share
$0.62
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
0
Total reported value
$0
Share change
-2,317
Value change
-$1,727
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% +100% $789,250 +$459,747 717,500 +140% Armistice Capital, LLC 31 Mar 2025

As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI). This represents 0% of the company’s total 6,002,966 outstanding shares.

Institutional Holders of BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$1,727 $0.62 0
2025 Q3 2,317 $1,727 -$261,339 $0.71 5
2025 Q2 235,778 $263,958 -$804,996 $1.12 33
2025 Q1 866,024 $1,091,190 +$799,420 $1.26 31
2024 Q4 208,625 $473,155 +$411,634 $2.27 30
2024 Q3 157,266 $36,709 +$36,709 $0.23 4